Data / Form D filings / Abrexa Pharmaceuticals, Inc.
Abrexa Pharmaceuticals, Inc.: Form D filings
Abrexa Pharmaceuticals, Inc., a health care company in San Diego, CA, filed 4 Form D notices with the SEC between 2011 and 2025. The latest, on April 28, 2025, reports $23 million sold of a $23 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 402 W Broadway, Suite 400, San Diego, CA, 92101
- Phone
- (619) 295-5077
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1529349
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2025 | New notice | $22,999,999 | $22,999,999 | 2 | Apr 10, 2025 | sec.gov | |
| Feb 7, 2019 | Amendment | $16,632,252 | $16,632,252 | 7 | Jul 25, 2018 | sec.gov | |
| Aug 8, 2018 | New notice | $7,632,252 | $7,632,252 | 7 | Jul 25, 2018 | sec.gov | |
| Sep 6, 2011 | New notice | $500,793 | $500,793 | 11 | Aug 25, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David J. Hughley | Director | |
| James J. Truchard | Director | |
| J. Ernest Villafranca | Executive Officer, Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Apr 28, 2025 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Abrexa Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.